Healthcare provider profile · identity verified

Barry Anthony Scanlan, DO

Internal Medicine · DALLAS, NC · NPI 1497712277

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	751	222
Atorvastatin Calcium	Atorvastatin Calcium	683	192
Levothyroxine Sodium	Levothyroxine Sodium	493	110
Amlodipine Besylate	Amlodipine Besylate	458	125
Pantoprazole Sodium	Pantoprazole Sodium	398	121
Omeprazole	Omeprazole	386	109
Jardiance	Empagliflozin	350	70
Clonazepam	Clonazepam	336	59
Carvedilol	Carvedilol	329	81
Losartan Potassium	Losartan Potassium	312	89
Tramadol Hcl	Tramadol Hcl	311	68
Simvastatin	Simvastatin	305	81
Ozempic	Semaglutide	303	60
Lisinopril	Lisinopril	283	74
Famotidine	Famotidine	271	76
Furosemide	Furosemide	266	86
Duloxetine Hcl	Duloxetine Hcl	264	62
Metoprolol Succinate	Metoprolol Succinate	261	78
Trazodone Hcl	Trazodone Hcl	240	73
Olmesartan Medoxomil	Olmesartan Medoxomil	238	62
Gabapentin	Gabapentin	231	71
Lorazepam	Lorazepam	195	33
Tamsulosin Hcl	Tamsulosin Hcl	183	52
Fluoxetine Hcl	Fluoxetine Hcl	178	56
Alendronate Sodium	Alendronate Sodium	175	55
Alprazolam	Alprazolam	175	27
Hydrochlorothiazide	Hydrochlorothiazide	175	47
Fenofibrate	Fenofibrate	174	50
Albuterol Sulfate Hfa	Albuterol Sulfate	168	33
Diclofenac Sodium	Diclofenac Sodium	166	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	159	37
Potassium Chloride	Potassium Chloride	154	48
Montelukast Sodium	Montelukast Sodium	150	37
Tizanidine Hcl	Tizanidine Hcl	148	41
Methylprednisolone	Methylprednisolone	141	107
Invokana	Canagliflozin	138	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	135	94
Allopurinol	Allopurinol	132	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	130	31
Clopidogrel	Clopidogrel Bisulfate	127	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	125	28
Metformin Hcl	Metformin Hcl	124	34
Sertraline Hcl	Sertraline Hcl	122	30
Pioglitazone Hcl	Pioglitazone Hcl	120	34
Trulicity	Dulaglutide	118	24
Zolpidem Tartrate	Zolpidem Tartrate	117	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	111	31
Pravastatin Sodium	Pravastatin Sodium	96	22
Eliquis	Apixaban	88	22
Fluticasone Propionate	Fluticasone Propionate	88	29
Myrbetriq	Mirabegron	84	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	83	28
Metoprolol Tartrate	Metoprolol Tartrate	82	26
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	75	16
Pregabalin	Pregabalin	75	19
Bupropion Xl	Bupropion Hcl	72	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	19
Xarelto	Rivaroxaban	70	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	22
Farxiga	Dapagliflozin Propanediol	65	14
Ropinirole Hcl	Ropinirole Hcl	65	15
Citalopram Hbr	Citalopram Hydrobromide	63	16
Esomeprazole Magnesium	Esomeprazole Magnesium	63	19
Klor-Con M20	Potassium Chloride	63	20
Amitriptyline Hcl	Amitriptyline Hcl	62	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	62	34
Celecoxib	Celecoxib	61	16
Meclizine Hcl	Meclizine Hcl	61	29
Synthroid	Levothyroxine Sodium	60	15
Ezetimibe	Ezetimibe	59	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	55	39
Aripiprazole	Aripiprazole	54	20
Tolterodine Tartrate Er	Tolterodine Tartrate	54	14
Fluconazole	Fluconazole	52	27
Paroxetine Hcl	Paroxetine Hcl	52	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	50	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	50	suppressed
Chlorthalidone	Chlorthalidone	49	11
Topiramate	Topiramate	47	suppressed
Diazepam	Diazepam	44	12
Buspirone Hcl	Buspirone Hcl	43	12
Clonidine Hcl	Clonidine Hcl	43	suppressed
Finasteride	Finasteride	42	12
Ondansetron Odt	Ondansetron	42	16
Testosterone	Testosterone	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	13
Doxycycline Hyclate	Doxycycline Hyclate	38	34
Ondansetron Hcl	Ondansetron Hcl	38	15
Spironolactone	Spironolactone	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Temazepam	Temazepam	34	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Nystatin	Nystatin	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Estradiol	Estradiol	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	30	11
Azelastine Hcl	Azelastine Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	12
Dutasteride	Dutasteride	27	suppressed
Ibu	Ibuprofen	27	suppressed
Nitroglycerin	Nitroglycerin	27	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Atenolol	Atenolol	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	11
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Metformin Hcl Er	Metformin Hcl	21	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	suppressed
Magnesium Sulfate	Magnesium Sulfate	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Niacin Er	Niacin	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	13
Victoza 3-Pak	Liraglutide	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	11
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Valsartan	Valsartan	17	suppressed
Baclofen	Baclofen	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Levofloxacin	Levofloxacin	16	11
Lidocaine-Prilocaine	Lidocaine/Prilocaine	16	suppressed
Lubiprostone	Lubiprostone	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Colchicine	Colchicine	15	suppressed
Glipizide	Glipizide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Prednisone	Prednisone	15	suppressed
Torsemide	Torsemide	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	12
Meloxicam	Meloxicam	14	suppressed
Victoza 2-Pak	Liraglutide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Halobetasol Propionate	Halobetasol Propionate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Primidone	Primidone	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Linzess	Linaclotide	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Prolia	Denosumab	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error